Evidence map›Paper›PMID 38477469›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients.

J Matthijs Biesbroek, Mirthe Coenen, Charles DeCarli, Evan M Fletcher, Pauline M Maillard, Alzheimer's Disease Neuroimaging Initiative, Frederik Barkhof, Josephine Barnes, Thomas Benke, Christopher P L H Chen and 32 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Post mortem MRI of cholinergic white matter pathways across neurodegenerative diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Vascular risk factors mediate the relationship between education and white matter hyperintensities.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Plasma NfL and GFAP for predicting VCI and related brain changes in community and clinical cohorts.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  17. Motoric Cognitive Risk Syndrome and Risk of Cardiovascular Disease: A Population-Based Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  18. White matter hyperintensity spatial patterns: Risk factors and clinical correlates.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 13 institutions in 8 countries.

J Matthijs BiesbroekDepartment of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.ORCID 0000-0001-7017-2148
Mirthe CoenenDepartment of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.
Charles DeCarliDepartment of Neurology, University of California at Davis, Davis, California, USA.
Evan M FletcherDepartment of Neurology, University of California at Davis, Davis, California, USA.
Pauline M MaillardDepartment of Neurology, University of California at Davis, Davis, California, USA.
Alzheimer's Disease Neuroimaging InitiativeDepartment of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.
Frederik BarkhofDepartment of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
Josephine BarnesDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Thomas BenkeClinic of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Christopher P L H ChenDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Peter Dal-BiancoDepartment of Neurology, Medical University Vienna, Vienna, Austria.
Anna DewenterInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
Marco DueringInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
Christian EnzingerDivision of General Neurology, Department of Neurology, Medical University Graz, Graz, Austria.
Michael EwersInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
Lieza G ExaltoDepartment of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.
Nicolai FranzmeierInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
Saima HilalDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Edith HoferDivision of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.
Huiberdina L KoekDepartment of Geriatric Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Andrea B MaierMemory, Aging and Cognition Center, National University Health System, Singapore, Singapore.
Cheryl R McCrearyDepartments of Clinical Neurosciences and Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Janne M PapmaAlzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Ross W PatersonDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Yolande A L PijnenburgAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Anna RubinskiInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, München, Germany.
Reinhold SchmidtDivision of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.
Jonathan M SchottDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Catherine F SlatteryDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Eric E SmithDepartments of Clinical Neurosciences and Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Carole H SudreMRC Unit for Lifelong Health and Ageing, and the Centre for Medical Image Computing, UCL, London, UK.
Rebecca M E SteketeeAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Charlotte E TeunissenDepartment of Clinical Chemistry, Neurochemistry Laboratory, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Esther van den BergAlzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Wiesje M van der FlierAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Narayanaswamy VenketasubramanianMemory, Aging and Cognition Center, National University Health System, Singapore, Singapore.
Vikram VenkatraghavanAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Meike W VernooijAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Frank J WoltersAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Xu XinDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Hugo J KuijfImage Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands.
Geert Jan BiesselsDepartment of Neurology and Neurosurgery, UMC Utrecht Brain Center, Utrecht, The Netherlands.
Erasmus MC · NLNational University of Singapore · SGUniversity Medical Center Utrecht · NLMedical University of Graz · ATUniversity of California, Davis · USAllen Institute for Brain Science · USInnsbruck Medical University · ATLMU Klinikum · DERaffles Institution · SGUK Dementia Research Institute · GBUniversity of Basel · CHAmsterdam Neuroscience · NLUniversity of Calgary · CA

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
Alzheimer's AssociationNIA NIH HHS P30 AG010129NIA NIH HHS P30 AG072972NIA NIH HHS U01 AG024904NIBIB NIH HHSNIH HHS U01 AG024904
6 · The paper itself

Abstract

introductionWhite matter hyperintensities (WMH) are associated with key dementia etiologies, in particular arteriolosclerosis and amyloid pathology. We aimed to identify WMH locations associated with vascular risk or cerebral amyloid-β

methodsIndividual patient data (n = 3,132; mean age 71.5 ± 9 years; 49.3% female) from 11 memory clinic cohorts were harmonized. WMH volumes in 28 regions were related to a vascular risk compound score (VRCS) and Aß42 status (based on cerebrospinal fluid or amyloid positron emission tomography), correcting for age, sex, study site, and total WMH volume.

resultsVRCS was associated with WMH in anterior/superior corona radiata (B = 0.034/0.038, p < 0.001), external capsule (B = 0.052, p < 0.001), and middle cerebellar peduncle (B = 0.067, p < 0.001), and Aß42-positive status with WMH in posterior thalamic radiation (B = 0.097, p < 0.001) and splenium (B = 0.103, p < 0.001). DISCUSSION: Vascular risk factors and Aß42 pathology have distinct signature WMH patterns. This regional vulnerability may incite future studies into how arteriolosclerosis and Aß42 pathology affect the brain's white matter. HIGHLIGHTS: Key dementia etiologies may be associated with specific patterns of white matter hyperintensities (WMH). We related WMH locations to vascular risk and cerebral Aβ42 status in 11 memory clinic cohorts. Aβ42 positive status was associated with posterior WMH in splenium and posterior thalamic radiation. Vascular risk was associated with anterior and infratentorial WMH. Amyloid pathology and vascular risk have distinct signature WMH patterns.

Indexed as

ArteriolosclerosisDementiaWhite MatterAgedAged, 80 and overAmyloid beta-PeptidesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedAmyloid beta-Peptidesamyloid pathologyarteriolosclerosisdementialesion patternwhite matter hyperintensities

Identifiers

PMID38477469
PMCPMC11032573
OpenAlexW4392761707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.